The last few weeks have been filled with substantial clearances and approvals in the diabetes tech arena.
Embecta kept the space warm by announcing it had won a nod from FDA for its disposable patch pump. The device is indicated for adults who require insulin to manage diabetes, including both type 1 and type 2.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,